XML 19 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Assets    
Cash and cash equivalents $ 69,418 $ 163,620
Investment securities, available-for-sale 271,924 365,416
Accounts receivable, net 17,343 5,903
Interest and other receivables 1,087 1,237
Inventory 5,248 4,175
Prepaid expenses 8,457 7,546
Total current assets 373,477 547,897
Property and equipment, net 2,662 3,081
Intangible assets, net 5,538 7,015
Restricted cash 2,475 2,375
Other assets 354 785
Total assets 384,506 561,153
Liabilities and stockholders’ equity    
Accounts payable 8,786 3,912
Accrued liabilities 40,244 36,029
Deferred revenue   2,644
Total current liabilities 49,030 42,585
Long-term liabilities 191 157
Total liabilities 49,221 42,742
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at December 31, 2017 and 2016; no shares issued and outstanding at December 31, 2017 and 2016
Common stock, $0.0001 par value; 225,000,000 shares authorized at December 31, 2017 and December 31, 2016; 124,410,552 shares and 121,367,169 shares issued and outstanding at December 31, 2017 and December 31, 2016, respectively 12 12
Additional paid-in capital 1,559,343 1,452,272
Accumulated deficit (1,223,671) (933,979)
Accumulated other comprehensive (loss) income (399) 106
Total stockholders’ equity 335,285 518,411
Total liabilities and stockholders’ equity $ 384,506 $ 561,153